Search Results - "de Haas, Nienke"
-
1
STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics
Published in Journal of immunology research (01-01-2019)“…The STAT signaling pathway is important in dendritic cell (DC) development and function. Tumor cells can induce STAT signaling, thereby inhibiting DC…”
Get full text
Journal Article -
2
Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
Published in Cancer Immunology, Immunotherapy (01-03-2020)“…Background Autologous dendritic cell (DC) vaccines can induce tumor-specific T cells, but their effect can be counteracted by immunosuppressive mechanisms…”
Get full text
Journal Article -
3
Improving cancer immunotherapy by targeting the STATe of MDSCs
Published in Oncoimmunology (02-07-2016)“…Cancer immunotherapy is a promising therapeutic avenue; however, in practice its efficacy is hampered by an immunosuppressive tumor microenvironment that…”
Get full text
Journal Article -
4
Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients
Published in Oncoimmunology (01-01-2021)“…Cancer immunotherapies have induced long-lasting responses in cancer patients including those with melanoma and head and neck squamous cell carcinoma (HNSCC)…”
Get full text
Journal Article -
5
Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity
Published in Oncotarget (15-08-2017)“…Platinum-based chemotherapeutics are amongst the most powerful anti-cancer drugs. Although their exact mechanism of action is not well understood, it is…”
Get full text
Journal Article -
6
Human CD1c+ DCs are critical cellular mediators of immune responses induced by immunogenic cell death
Published in Oncoimmunology (02-08-2016)“…Chemotherapeutics, including the platinum compounds oxaliplatin (OXP) and cisplatin (CDDP), are standard care of treatment for cancer. Although chemotherapy…”
Get full text
Journal Article -
7
Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients
Published in Scientific reports (07-03-2017)“…Keyhole limpet hemocyanin (KLH) is used as an immunogenic neo-antigen for various clinical applications and during vaccine development. For advanced monitoring…”
Get full text
Journal Article -
8
Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition
Published in Journal of translational medicine (14-04-2016)“…Melanoma is the most lethal type of skin cancer and its incidence is progressively increasing. The introductions of immunotherapy and targeted therapies have…”
Get full text
Journal Article